Parametric Portfolio Associates’s Maravai LifeSciences MRVI Stock Holding History

Parametric Portfolio Associates’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.02M	Sell	28,893 -26,783	-48%	-$898K	﹤0.01%	2780
2021 Q4	$2.33M	Sell	55,676 -15,265	-22%	-$618K	﹤0.01%	2347
2021 Q3	$3.48M	Buy	70,941 +41,285	+139%	+$2.01M	﹤0.01%	2086
2021 Q2	$1.24M	Buy	29,656 +11,019	+59%	+$427K	﹤0.01%	2676
2021 Q1	$664K	Buy	+18,637	New	+$617K	﹤0.01%	3353

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's MRVI Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Maravai LifeSciences (MRVI) stake by 48% in Q1 2022, selling an estimated $898K and leaving 28,893 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Parametric Portfolio Associates first reported a position in MRVI in Q1 2021 and has held it in 5 quarters since. The position peaked at $3.48M in Q3 2021. 235 funds tracked by Wall St. Rank hold MRVI as of Q1 2022.

Parametric Portfolio Associates held 28,893 shares of Maravai LifeSciences worth $1.02M as of Q1 2022.
Parametric Portfolio Associates sold 26,783 Maravai LifeSciences shares in Q1 2022, an estimated $898K.
Maravai LifeSciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2780 holding.
Parametric Portfolio Associates first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 5 quarters since.
Parametric Portfolio Associates's Maravai LifeSciences position peaked at $3.48M in Q3 2021.
235 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.